United States: Food and Drug Administration [clinicaltrials_resource:64688518b5fa69f7160a05bc68ec4e23]
ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) [clinicaltrials:NCT00041509]Intralesional PV-10 Chemoablation of Metastatic Melanoma [clinicaltrials:NCT00219843]Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00291486]clinicaltrials:NCT00296504clinicaltrials:NCT00314132clinicaltrials:NCT00314145A Study of LY573636 in Treating Patients With Malignant Melanoma [clinicaltrials:NCT00383292]clinicaltrials:NCT00521053clinicaltrials:NCT00533273Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [clinicaltrials:NCT00658086]clinicaltrials:NCT00700063clinicaltrials:NCT00740584clinicaltrials:NCT00742391To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion [clinicaltrials:NCT00857168]clinicaltrials:NCT00915551clinicaltrials:NCT00916006A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study [clinicaltrials:NCT00952783]clinicaltrials:NCT00953732A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study [clinicaltrials:NCT00989313]Testosterone MD-Lotion Residual Washing Study [clinicaltrials:NCT00996151]Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload [clinicaltrials:NCT01039636]A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application [clinicaltrials:NCT01172366]clinicaltrials:NCT01365650An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors [clinicaltrials:NCT01406119]clinicaltrials:NCT01407068clinicaltrials:NCT01682616Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis [clinicaltrials:NCT02026401]clinicaltrials:NCT02103335Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2 [clinicaltrials:NCT02107313]Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine [clinicaltrials:NCT02109497]Florbetapir Calibration to the Centiloid Scale [clinicaltrials:NCT02120664]Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis [clinicaltrials:NCT02135536]Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema [clinicaltrials:NCT02167659]Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia [clinicaltrials:NCT02221505]IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) [clinicaltrials:NCT02232425]Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer [clinicaltrials:NCT02262910]A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) [clinicaltrials:NCT02275351]clinicaltrials:NCT02336165
oversight [clinicaltrials_vocabulary:oversight]
United States: Food and Drug Administration [clinicaltrials_resource:64688518b5fa69f7160a05bc68ec4e23]
Bio2RDF identifier
64688518b5fa69f7160a05bc68ec4e23
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:64688518b5fa69f7160a05bc68ec4e23
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:64688518b5fa69f7160a05bc68ec4e23
title
United States: Food and Drug Administration
@en
type
label
United States: Food and Drug A ...... 88518b5fa69f7160a05bc68ec4e23]
@en